Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles Romeo is active.

Publication


Featured researches published by Charles Romeo.


Cell | 1993

T cell activation by clustered tyrosine kinases.

Waldemar Kolanus; Charles Romeo; Brian Seed

Many cellular recognition events in the immune system are initiated by aggregation of cell surface receptors that lack intrinsic protein-tyrosine kinase activity. Receptor-associated kinases related to the src protooncogene product have been found to be essential for cellular activation and may interact with the cytoplasmic domains of the antigen receptor chains. We show here that anti-CD16 antibody-mediated clustering of chimeric transmembrane proteins bearing a CD16 extracellular domain and a Src family kinase intracellular domain is not sufficient to initiate a cellular activation signal in T cells, whereas clustering of similar chimeras bearing Syk or ZAP-70 kinase sequences triggers calcium mobilization. Aggregation of the Syk chimera alone, or coaggregation of chimeras bearing Fyn and ZAP-70 kinases, suffices to initiate cytolytic effector function. The pattern of tyrosine phosphorylation induced by clustering of the Syk chimera is similar to the pattern induced by aggregation of T cell receptor.


Cell | 1991

Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides

Charles Romeo; Brian Seed

We describe functional simplified T cell and Fc receptor chimeras that are capable of directing CD8+ cytotoxic T lymphocytes (CTLs) to specifically recognize and lyse cells expressing HIV envelope proteins. Target cells bearing HLA-DR molecules are not recognized by CTL armed with the chimeras. The variety of cell types in which the native receptors are active suggests multiple possibilities for antiviral intervention through genetic means.


The EMBO Journal | 1992

Lineage-independent activation of immune system effector function by myeloid Fc receptors.

Waldemar Kolanus; Charles Romeo; Brian Seed

An emerging theme in immunology finds receptors which initiate cellular effector programs forming multichain complexes in which the ligand recognition elements associate with one or more ‘trigger molecules’ whose aggregation initiates a signal transduction cascade. The sequence motifs constituting the active sites of these trigger molecules are found in the T cell and B cell antigen receptors, and some Fc receptors, and appear to be central to effector function activation. For example, of the many molecules that mimic or potentiate the action of the T cell antigen receptor (TCR), none have yet been found to initiate effector programs autonomously in cells lacking TCR. We have devised two strategies to study activation mediated by myeloid Fc receptors, which appear not to associate with trigger molecules: the use of primary human cytolytic T cells as surrogate effector cells for genetically delivered receptors, and the use of vaccinia virus vectors to introduce genetically modified receptors into primary human monocytes. Using these approaches, we have found that the cytoplasmic domains of two Fc receptors show comparable function to equivalent domains of the trigger molecule family, but are not homologous to members of that family.


Advances in Experimental Medicine and Biology | 1994

Nonreceptor Tyrosine Kinases in Aggregation-Mediated Cell Activation

Brian Seed; Waldemar Kolanus; Charles Romeo; Ramnik J. Xavier

Many of the cellular recognition events in the immune system which are mediated by cell surface receptors are initiated by cell-cell contacts which result in receptor aggregation. Almost universally, the relevant receptors lack intrinsic enzymatic activity. However a growing body of evidence suggests that tyrosine phosphorylation is an early concomitant of cellular activation initiated by aggregation of cell surface receptors, and in some cases a causal role for tyrosine kinases in the activation process can be identified.


Cell | 1995

Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps

J. Fraser McBlane; Dik C. van Gent; Dale A. Ramsden; Charles Romeo; Christina A. Cuomo; Martin Gellert; Marjorie A. Oettinger


Archive | 1994

Redirection of cellular immunity by receptor chimeras

Brian Seed; Charles Romeo; Waldemar Kolanus


Archive | 1996

Redirection of cellular immunity by protein-tyrosine kinase chimeras

Brian Seed; Charles Romeo; Waldemar Kolanus


Archive | 1995

Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells

Brian Seed; Babak Banapour; Charles Romeo; Waldemar Kolanus


Cold Spring Harbor Symposia on Quantitative Biology | 1992

Activation of Immune System Effector Function by T-cell or Fc Receptor Intracellular Domains

Charles Romeo; Waldemar Kolanus; Martine Amiot; Brian Seed


Journal of Biological Chemistry | 1994

Association of Raf with the CD3 delta and gamma chains of the T cell receptor-CD3 complex.

C Loh; Charles Romeo; Brian Seed; J T Bruder; U Rapp; A Rao

Collaboration


Dive into the Charles Romeo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dale A. Ramsden

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Dik C. van Gent

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

J. Fraser McBlane

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Gellert

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge